患有心房动和左心室功能障碍的患者的手术切除:系统性审查和元分析
Leo Noanh Consoli1, Eren Cetinel2, Mir Wajid Majeed3
1Federal University of Bahia, Bahia, Brazil.
International journal of cardiology. Heart & vasculature
|March 31, 2025
概括
手术切除 (SA) 能够有效地恢复心房动 (AF) 和左心室功能障碍 (LVD) 的患者的鼻节律. 这一元分析显示,SA的成功率很高,可接受的30天死亡率,这表明它作为节律控制策略的承诺.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 电力生理学 电力生理学
背景情况:
- 在心脏病患者中,心房动 (AF) 和左心室功能障碍 (LVD) 经常同时存在.
- 手术切除 (SA) 是一种潜在的治疗方法,但其在这个特定人群中的疗效和安全性需要进一步研究.
研究的目的:
- 评估AF和LVD诊断的成年患者中独立和并发SA的结果.
- 评估SA在维持鼻节律和改善心脏功能方面的有效性.
主要方法:
- 进行了一个单臂元分析,搜索了PubMed,Scopus和Cochrane图书馆.
- 包括10项与863名患者进行的观察性研究,分析了诸如鼻节律维持,抗失常药物 (AAD) 使用,LVEF变化和死亡率等终点.
主要成果:
- 一年后,SA在81.6%的患者中实现了83.9%的鼻节律率,并且在81.6%的患者中无需使用AAD.
- 综合30天死亡率为2.2%,LVEF显著改善12% (95% CI:9-17).
- 大型手术并发症发生在16.73%的患者中.
结论:
- 手术切除 (SA) 证明了在患有AF和LVD的患者中实现鼻节律的有效性.
- 总的30天死亡率为2.2%,表明安全性概况有利.
- 建议进行进一步的比较研究,以评估SA与替代节律控制策略之间的比较.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
01:26Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
01:25Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
01:25Dysrhythmias VI: Management of Dysrhythmias
598
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598
01:29Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761